Corrigendum to “Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation” [Contemp. Clin. Trials Commun. 33 (2023) 101144]

• Carmen Cuffari,
• William Spalding,
• Heinrich Achenbach,
• Manoj Thakur,
• André Gabriel

Affiliations

Carmen Cuffari

Children's National Hospital, Division of Gastroenterology, Hepatology and Nutrition, Washington, DC, USA; Corresponding author. 600 North Wolfe Street, Baltimore, MD, 21287, USA.

William Spalding

Takeda Development Center Americas, Inc., Lexington, MA, USA

Heinrich Achenbach

Takeda Development Center Americas, Inc., Zurich, Switzerland

Manoj Thakur

Takeda Development Center Americas, Inc., Lexington, MA, USA

André Gabriel

Takeda Development Center Americas, Inc., Lexington, MA, USA